Year-over-year earnings per share growth for the last twelve months: MAIA Biotechnology (MAIA)
MAIA Biotechnology is developing THIO, an innovative drug designed to combat cancer by targeting telomeres. The quarterly EPS evolution metric demonstrates profit dynamics, where 55.50 represents the current level of the metric. The strategy is based on treating non-small cell lung cancer with the support of insurance systems, which provides the brand with high authority within the scientific community.
Comprehensive metric breakdowns and analytics for MAIA Bio (MAIA)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt and liquidity details:
- earnings and market multiples details:
MAIA - Final Profit|Projected Future Earnings MAIA Biotechnology|MAIA - Market Cap to Earnings|Future Price to Earnings MAIA Biotechnology Inc|MAIA - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple MAIA Biotechnology Inc|MAIA - Operating profit EBITDA|Earnings per share for the last twelve months MAIA Biotechnology|MAIA - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months MAIABiotech.com|MAIA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year MAIA Biotechnology
Comprehensive company analysis:MAIA Biotechnology, Inc., MAIA
For asset stress testing, it is critical for investors to evaluate the rate of change in net earnings per share, which measures capital allocation efficiency and business resilience to market shocks. Since MAIA Biotechnology is in the early stages of therapy development without commercial sales, the quarterly earnings per share trend reflects only the cash burn rate, confirming the speculative nature of the current valuation.
Competitors of MAIA Biotechnology
IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Janux Pharma|Year-over-year net earnings per share growth for the last 12 months Arcus Corp (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc. (ZYME)|Year-over-year net earnings per share growth for the last 12 months tangotx.com TNGX|Iovance Biotherapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics NV IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (Compass Therapeutics Corp) - Year-over-year earnings per share growth for the last 12 months|Replimune Group, Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months lyell.com (LYEL)|Year-over-year net earnings per share growth for the last 12 months IPHA|PYXS - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months CGEN (Compugen Ltd.)|Year-over-year earnings per share growth rate for the last twelve months IOBT|Quarterly EPS earnings growth STRO (Sutro Biopharma, Inc.)|Year-over-year earnings per one share growth for the last 12 months INKT|Werewolf - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immix Biopharma, Inc.|ALX Oncology (ALXO) - Year-over-year earnings per share growth for the last twelve months|Cue Biopharma Inc. - Year-over-year earnings per one share growth for the last 12 months|PDSB (PDS Biotech) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Sonnet BioTherapeutics Holdings Inc.|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Corp - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics Inc (LPTX) - Earnings per share growth in annualized terms for the last twelve months|INTS - Year-over-year earnings per share growth for the last twelve months|Sensei Biotherapeutics (SNSE) - Year-over-year net earnings per share growth for the last 12 months|TOVX: Quarterly EPS earnings growth|Gritstone bio (GRTS) - Quarterly EPS earnings growth|KA (Kineta Bio) - Quarterly EPS earnings growth|NexImmune Corporation (NEXI) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth TSBX|Quarterly EPS earnings growth vaccinex.com (VCNX)|Harpoon Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months
